Cresp 40mcg Injection

About Cresp 40mcg Injection

Cresp 40mcg Injection contains Darbepoetin Alfa is a frequently prescribed drug used to treat Anemia by injection, especially in patients receiving chemotherapy or chronic kidney disease (CKD). It contains a recombinant human erythropoiesis-stimulating agent (ESA) called Darbepoetin Alfa, whose purpose is to imitate the actions of the hormone erythropoietin in nature.

Although Cresp 40 Injection might have dangerous side effects, it must be used carefully and under the guidance of a medical professional with experience. For safe and efficient treatment, carefully adhere to the doctor's directions.

Brand Name: Cresp

Composition: Darbepoetin Alfa

Mechanism of Action:

Darbepoetin Alfa increases the marrow's ability to produce red blood cells (RBCs), which increases the blood's ability to carry oxygen. It functions similarly to erythropoietin produced by the body naturally, but because of its longer half-life, fewer doses are required.

Uses:

• Anemia in Chronic Kidney Disease (CKD)
• Chemotherapy-Induced Anemia
• Anemia in Certain Surgical Patients.

Side Effects:

• Hypertension
• Joint Pain
• Injection Site Reactions
• Breathlessness
• Cough
• Peripheral edema
• Thromboembolic Events
• Seizures
• Pure Red Cell Aplasia (PRCA)

Dosage and Administration:

The patient's hemoglobin levels and the underlying cause of the anemia determine the dosage and frequency. Either intravenously (into a vein) or subcutaneously (under the skin), typically once a week or as prescribed by a healthcare professional.